|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Open Access
Best Reviewer Awardees
Article Processing Charge
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Agreement
Journal Archive
Accepted Articles
Epub Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Cancer Research and Treatment
Search
Author Index
Cancer Research and Treatment
Search
> Browse Articles > Search
Hematologic malignancy
Differing Outcomes of Patients with High Hyperdiploidy and
ETV6
-
RUNX1
Rearrangement in Korean Pediatric Precursor B Cell Acute Lymphoblastic Leukemia
Jae Wook Lee, Seongkoo Kim, Pil-Sang Jang, Nack-Gyun Chung, Bin Cho
Cancer Res Treat.
2021;53(2):567-575. Published online October 8, 2020 DOI:
https://doi.org/10.4143/crt.2020.507
Lymphoma
Prognostic Impact of Age at the Time of Diagnosis in Korean Patients with Diffuse Large B-cell
Lymphoma
in the Rituximab Era: A Single Institution Study
Hee Sang Hwang, Meejeong Kim, Chan-Sik Park, Dok Hyun Yoon, Cheolwon Suh, Jooryung Huh, Heounjeong Go
Cancer Res Treat.
2021;53(1):270-278. Published online September 15, 2020 DOI:
https://doi.org/10.4143/crt.2020.626
Crohn’s Disease Following Rituximab Treatment for Follicular
Lymphoma
in a Patient with Synchronous Gastric Signet Ring Cells Carcinoma: A Case Report and Literature Review
Elisabetta Cavalcanti, Raffaele Armentano, Ivan Lolli
Cancer Res Treat.
2020;52(4):1291-1295. Published online July 13, 2020 DOI:
https://doi.org/10.4143/crt.2020.406
Cited By 1
Lymphoma
Forkhead Box C1 (FOXC1) Expression in Stromal Cells within the Microenvironment of T and NK Cell
Lymphoma
s: Association with Tumor Dormancy and Activation
Ji Hae Nahm, Woo Ick Yang, Sun Och Yoon
Cancer Res Treat.
2020;52(4):1273-1282. Published online July 3, 2020 DOI:
https://doi.org/10.4143/crt.2020.032
Increasing Incidence of B-Cell Non-Hodgkin
Lymphoma
and Occurrence of Second Primary Malignancies in South Korea: 10-Year Follow-up Using the Korean National Health Information Database
Jin Seok Kim, Yanfang Liu, Kyoung Hwa Ha, Hong Qiu, Lee Anne Rothwell, Hyeon Chang Kim
Cancer Res Treat.
2020;52(4):1262-1272. Published online May 4, 2020 DOI:
https://doi.org/10.4143/crt.2020.089
A Modified NHL-BFM-95 Regimen Produces Better Outcome Than HyperCVAD in Adult Patients with T-Lymphoblastic
Lymphoma
, a Two-Institution Experience
Chun Li, Zhi-Jun Wuxiao, Xiaoqin Chen, Guanjun Chen, Yue Lu, Zhongjun Xia, Yang Liang, Hua Wang
Cancer Res Treat.
2020;52(2):573-585. Published online December 6, 2019 DOI:
https://doi.org/10.4143/crt.2019.542
Cited By 1
Detection of Targetable Genetic Alterations in Korean Lung Cancer Patients: A Comparison Study of Single-Gene Assays and Targeted Next-Generation Sequencing
Eunhyang Park, Hyo Sup Shim
Cancer Res Treat.
2020;52(2):543-551. Published online November 8, 2019 DOI:
https://doi.org/10.4143/crt.2019.305
Cited By 3
Efficacy of Brentuximab Vedotin in Relapsed or Refractory High-CD30–Expressing Non-Hodgkin
Lymphoma
s: Results of a Multicenter, Open-Labeled Phase II Trial
Seok Jin Kim, Dok Hyun Yoon, Jin Seok Kim, Hye Jin Kang, Hye Won Lee, Hyeon-Seok Eom, Jung Yong Hong, Junhun Cho, Young Hyeh Ko, Jooryung Huh, Woo-Ick Yang, Weon Seo Park, Seung-Sook Lee, Cheolwon Suh, Won Seog Kim
Cancer Res Treat.
2020;52(2):374-387. Published online August 13, 2019 DOI:
https://doi.org/10.4143/crt.2019.198
Cited By 5
Clinical Characteristics and Treatment Outcomes of Pediatric Patients with Non-Hodgkin
Lymphoma
in East Asia
Jin Kyung Suh, Yi-Jin Gao, Jing-Yan Tang, Shiann-Tarng Jou, Dong-Tsamn Lin, Yoshiyuki Takahashi, Seiji Kojima, Ling Jin, Yonghong Zhang, Jong Jin Seo
Cancer Res Treat.
2020;52(2):359-368. Published online July 29, 2019 DOI:
https://doi.org/10.4143/crt.2019.219
Diffuse Large B-Cell
Lymphoma
Arising within Ileal Neobladder: An Expanding Spectrum of Diffuse Large B-Cell
Lymphoma
Associated with Chronic Inflammation
Hyekyung Lee, Hyunbin Shin, Nae Yu Kim, Hyun Sik Park, Jinsung Park
Cancer Res Treat.
2019;51(4):1666-1670. Published online March 22, 2019 DOI:
https://doi.org/10.4143/crt.2019.022
Characteristics, Prognostic Factors, and Survival of Patients with NK/T-Cell
Lymphoma
of Non-upper Aerodigestive Tract: A 17-Year Single-Center Experience
Ze-Long Liu, Xi-Wen Bi, Xue-Wen Zhang, De-Xin Lei, Pan-Pan Liu, Hang Yang, Yan Gao, Yuan-Xue Jiang, Wen-Qi Jiang, Yi Xia
Cancer Res Treat.
2019;51(4):1557-1567. Published online April 1, 2019 DOI:
https://doi.org/10.4143/crt.2018.681
Prognostic Value of Baseline and Interim Total Metabolic Tumor Volume and Total Lesion Glycolysis Measured on 18F-FDG PET-CT in Patients with Follicular
Lymphoma
Jin-Hua Liang, Yun-Ping Zhang, Jun Xia, Chong-Yang Ding, Wei Wu, Li Wang, Lei Cao, Hua-Yuan Zhu, Lei Fan, Tian-Nv Li, Jian-Yong Li, Wei Xu
Cancer Res Treat.
2019;51(4):1479-1487. Published online March 12, 2019 DOI:
https://doi.org/10.4143/crt.2018.649
Cited By 2
Body Cavity–Based
Lymphoma
in a Country with Low Human Immunodeficiency Virus Prevalence: A Series of 17 Cases from the Consortium for Improving Survival of
Lymphoma
Junghoon Shin, Young Hyeh Ko, Sung Yong Oh, Dok Hyun Yoon, Jeong-Ok Lee, Jin Seok Kim, Yong Park, Ho Jin Shin, Seok Jin Kim, Jong Ho Won, Sung-Soo Yoon, Won Seog Kim, Youngil Koh, On behalf of the Consortium for Improving Survival of
Lymphoma
investigators
Cancer Res Treat.
2019;51(4):1302-1312. Published online February 14, 2019 DOI:
https://doi.org/10.4143/crt.2018.555
Cited By 3
Alterations in PD-L1 Expression Associated with Acquisition of Resistance to ALK Inhibitors in ALK-Rearranged Lung Cancer
Su-Jung Kim, Soyeon Kim, Dong-Wan Kim, Miso Kim, Bhumsuk Keam, Tae Min Kim, Yusoo Lee, Jaemoon Koh, Yoon Kyung Jeon, Dae Seog Heo
Cancer Res Treat.
2019;51(3):1231-1240. Published online December 31, 2018 DOI:
https://doi.org/10.4143/crt.2018.486
Cited By 7
Dose-Dense Rituximab-CHOP versus Standard Rituximab-CHOP in Newly Diagnosed Chinese Patients with Diffuse Large B-Cell
Lymphoma
: A Randomized, Multicenter, Open-Label Phase 3 Trial
Xueying Li, He Huang, Bing Xu, Hongqiang Guo, Yingcheng Lin, Sheng Ye, Jiqun Yi, Wenyu Li, Xiangyuan Wu, Wei Wang, Hongyu Zhan, Derong Xie, Jiewen Peng, Yabing Cao, Xingxiang Pu, Chengcheng Guo, Huangming Hong, Zhao Wang, Xiaojie Fang, Yong Zhou, Suxia Lin, Qing Liu, Tongyu Lin
Cancer Res Treat.
2019;51(3):919-932. Published online October 2, 2018 DOI:
https://doi.org/10.4143/crt.2018.230
Cited By 5
Comparison of Efficacy of Pembrolizumab between Epstein-Barr Virus‒Positive and ‒Negative Relapsed or Refractory Non-Hodgkin
Lymphoma
s
Seok-Jin Kim, Jiyeon Hyeon, Inju Cho, Young Hyeh Ko, Won Seog Kim
Cancer Res Treat.
2019;51(2):611-622. Published online July 20, 2018 DOI:
https://doi.org/10.4143/crt.2018.191
Cited By 23
Radiation Therapy Outcome and Clinical Features of Duodenal-Type Follicular
Lymphoma
Hansang Lee, Dongryul Oh, Kyungmi Yang, Young Hyeh Ko, Yong Chan Ahn, Won Seog Kim, Seok Jin Kim
Cancer Res Treat.
2019;51(2):547-555. Published online July 10, 2018 DOI:
https://doi.org/10.4143/crt.2018.190
Cited By 4
Circulating Low Absolute CD4
+
T Cell Counts May Predict Poor Prognosis in Extranodal NK/T-Cell
Lymphoma
Patients Treating with Pegaspargase-Based Chemotherapy
Ya-Ping Zhang, Run Zhang, Hua-Yuan Zhu, Li Wang, Yu-Jie Wu, Jin-Hua Liang, Wen-Yu Shi, Hong Liu, Wei Xu, Jian-Yong Li
Cancer Res Treat.
2019;51(1):368-377. Published online May 14, 2018 DOI:
https://doi.org/10.4143/crt.2018.010
Cited By 2
The Prognostic Role of Circulating Epstein-Barr Virus DNA Copy Number in Angioimmunoblastic T-Cell
Lymphoma
Treated with Dose-Adjusted EPOCH
Jin-Hua Liang, Luo Lu, Hua-Yuan Zhu, Wang Li, Lei Fan, Jian-Yong Li, Wei Xu
Cancer Res Treat.
2019;51(1):150-157. Published online April 2, 2018 DOI:
https://doi.org/10.4143/crt.2017.476
Cited By 4
Delayed Terminal Ileal Perforation in a Relapsed/Refractory B-Cell
Lymphoma
Patient with Rapid Remission Following Chimeric Antigen Receptor T-Cell Therapy
Yongxian Hu, Jiasheng Wang, Chengfei Pu, Kui Zhao, Qu Cui, Guoqing Wei, Wenjun Wu, Lei Xiao, Yang Xiao, Jinping Wang, Zhao Wu, He Huang
Cancer Res Treat.
2018;50(4):1462-1466. Published online February 5, 2018 DOI:
https://doi.org/10.4143/crt.2017.473
Cited By 6
HBsAg-Negative, Anti-HBc–Negative Patients Still Have a Risk of Hepatitis B Virus–Related Hepatitis after Autologous Stem Cell Transplantation for Multiple Myeloma or Malignant
Lymphoma
Hyunsung Park, Do Young Kim, Soo-Jeong Kim, Haerim Chung, Hyunsoo Cho, Ji Eun Jang, June-Won Cheong, Yoo Hong Min, Jae-Woo Song, Jin Seok Kim
Cancer Res Treat.
2018;50(4):1121-1129. Published online December 4, 2017 DOI:
https://doi.org/10.4143/crt.2017.329
Cited By 1
Health-Related Quality of Life in Non-Hodgkin
Lymphoma
Survivors: A Prospective Cohort Study
Danbee Kang, Juhee Cho, Im Ryung Kim, Mi Kyung Kim, Won Seog Kim, Seok Jin Kim
Cancer Res Treat.
2018;50(4):1051-1063. Published online November 9, 2017 DOI:
https://doi.org/10.4143/crt.2017.207
Cited By 6
Comparison of Native
Escherichia coli
L-Asparaginase versus Pegylated Asparaginase, in Combination with Ifosfamide, Methotrexate, Etoposide, and Prednisolone, in Extranodal NK/T-Cell
Lymphoma
, Nasal Type
Hyun Jee Kim, Chan-Young Ock, Tae Min Kim, Sung Hee Lee, Ju-Yeun Lee, Sun hoi Jung, Yoon Sook Cho, Miso Kim, Bhumsuk Keam, Dong-Wan Kim, Il Han Kim, Dae Seog Heo
Cancer Res Treat.
2018;50(3):670-680. Published online July 3, 2017 DOI:
https://doi.org/10.4143/crt.2017.051
Cited By 4
Crizotinib in Combination with Everolimus Synergistically Inhibits Proliferation of Anaplastic
Lymphoma
Kinase‒Positive Anaplastic Large Cell
Lymphoma
Wendan Xu, Ji-Won Kim, Woo June Jung, Youngil Koh, Sung-Soo Yoon
Cancer Res Treat.
2018;50(2):599-613. Published online June 19, 2017 DOI:
https://doi.org/10.4143/crt.2016.357
Cited By 2
Multicenter Retrospective Analysis of Clinical Characteristics, Treatment Patterns, and Outcomes in Very Elderly Patients with Diffuse Large B-Cell
Lymphoma
: The Korean Cancer Study Group LY16-01
Jung Hye Choi, Tae Min Kim, Hyo Jung Kim, Sung Ae Koh, Yeung-Chul Mun, Hye Jin Kang, Yun Hwa Jung, Hyeok Shim, So Young Chong, Der-Sheng Sun, Soonil Lee, Byeong Bae Park, Jung Hye Kwon, Seung-Hyun Nam, Jun Ho Yi, Young Jin Yuh, Jong-Youl Jin, Jae Joon Han, Seok-Hyun Kim
Cancer Res Treat.
2018;50(2):590-598. Published online June 9, 2017 DOI:
https://doi.org/10.4143/crt.2017.172
Cited By 3
Low-Dose Radiation Therapy for Primary Conjunctival Marginal Zone B-Cell
Lymphoma
Ga-In Lee, Dongryul Oh, Won Seog Kim, Seok Jin Kim, Young Hyeh Ko, Kyung In Woo, Yoon-Duck Kim, Yong Chan Ahn
Cancer Res Treat.
2018;50(2):575-581. Published online June 16, 2017 DOI:
https://doi.org/10.4143/crt.2017.182
Cited By 8
ALK Protein Expression Is Related to Neuroblastoma Aggressiveness But Is Not Independent Prognostic Factor
Ji Won Lee, Sung Hye Park, Hyoung Jin Kang, Kyung Duk Park, Hee Young Shin, Hyo Seop Ahn
Cancer Res Treat.
2018;50(2):495-505. Published online May 22, 2017 DOI:
https://doi.org/10.4143/crt.2016.577
Cited By 3
Validation of the Korean Version of the Quality of Life–Cancer Survivors (QOL-CS-K) Questionnaire in
Lymphoma
Survivors
Juhee Cho, Danbee Kang, Im Ryung Kim, Won Seog Kim, Betty Ferrell, Seok Jin Kim
Cancer Res Treat.
2018;50(1):204-211. Published online March 30, 2017 DOI:
https://doi.org/10.4143/crt.2017.091
Cited By 4
Human Herpesvirus 8–Unrelated Primary Effusion
Lymphoma
–Like
Lymphoma
in an Elderly Korean Patient with a Good Response to Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone
Junghoon Shin, Jeong-Ok Lee, Ji-Young Choe, Soo-Mee Bang, Jong-Seok Lee
Cancer Res Treat.
2017;49(1):274-278. Published online June 10, 2016 DOI:
https://doi.org/10.4143/crt.2016.076
Cited By 4
Comparison of Total Body Irradiation (TBI) Conditioning with Non-TBI for Autologous Stem Cell Transplantation in Newly Diagnosed or Relapsed Mature T- and NK-Cell Non-Hodgkin
Lymphoma
Chi Hoon Maeng, Young Hyeh Ko, Do Hoon Lim, Eun Suk Kang, Joon Young Choi, Won Seog Kim, Seok Jin Kim
Cancer Res Treat.
2017;49(1):92-103. Published online May 9, 2016 DOI:
https://doi.org/10.4143/crt.2015.476
Cited By 1
1
2
3
4